BCDA Stock Analysis: Buy, Sell, or Hold?
BCDA - BioCardia, Inc. Common Stock
$0.83
-0.05 (-5.23%)
▼
5d:
-9.35%
30d:
-23.49%
90d:
-34.33%
HOLD
MODERATE Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When BCDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BCDA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BCDA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BCDA is currently trading at $0.83, which is considered oversold relative to its 30-day fair value range of $0.86 to $1.04.
Technical Outlook: Technically, BCDA is in a strong downtrend. Immediate support is located at $0.78, while resistance sits at $1.80. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: BCDA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.50 (+1661.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BCDA is in a strong downtrend. Immediate support is located at $0.78, while resistance sits at $1.80. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: BCDA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.50 (+1661.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.86 -
$1.04
Company Quality Score
40/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-5.2%)
- BULLISH: Trading 1661.4% below Wall St target ($15.50)
- CAUTION: 5-day price weakness (-9.3%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.86 -
$1.04
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.78
Resistance Level
$1.80
Current Trend
Strong Downtrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.47
Wall Street Target
$15.50
(+1661.4%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 15, 2026 12:38 PM ET
Data refreshes hourly during market hours. Next update: 1:38 PM
Data refreshes hourly during market hours. Next update: 1:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCDA showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Peter Altman
BUY
400 shares
2026-04-21
Peter Altman
BUY
600 shares
2026-04-20
Peter Altman
BUY
5000 shares
2026-02-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 54 HOLD |